Related Experiment Video
Updated: Aug 2, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Mucocutaneous Manifestations in Kidney Transplant Patients: Risk Factors
Yasmina El Arabi1, Fouzia Hali1, Yasmine Mahdar1
1Dermatology, Ibn Rochd University Hospital, Casablanca, MAR.
Kidney transplant patients face mucocutaneous complications, often infectious. Risk factors include older age, male gender, anemia, non-identical donors, and specific immunosuppressants like Tacrolimus and Thymoglobulin.
Area of Science:
- Nephrology
- Dermatology
- Immunology
Background:
- Kidney transplant recipients frequently experience mucocutaneous complications.
- These complications are often linked to drug toxicity and immunosuppression.
- Identifying risk factors is crucial for patient management.
Purpose of the Study:
- To determine the risk factors associated with mucocutaneous complications in kidney transplant patients.
- To analyze the characteristics of patients developing these complications.
Main Methods:
- A prospective analytical study was conducted from January 2020 to June 2021.
- 86 kidney transplant patients were recruited and analyzed.
- Statistical analysis identified significant risk factors (p<0.05).
Main Results:
- Thirty patients (34.9%) developed mucocutaneous complications.
- Infectious manifestations (53.4%) were most common, followed by inflammatory ones (36.6%).
- Advanced age, male gender, anemia, HLA non-identical donor, Tacrolimus, and Thymoglobulin were significant risk factors.
Conclusions:
- Infectious mucocutaneous complications are prevalent in renal transplant recipients.
- Key risk factors include advanced age, male gender, anemia, HLA non-identical donor, Tacrolimus, and Thymoglobulin.
- Early identification and management of these factors can improve patient outcomes.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome I : Introduction

